Pharmacology, Toxicology and Pharmaceutical Science
Squamous Cell Carcinoma
100%
microRNA
61%
microRNA 200b
50%
Epidermolysis Bullosa Dystrophica
50%
Ischemic Cardiomyopathy
50%
Heart Infarction
50%
Proteoglycan
50%
Proteochondroitin Sulfate
50%
Protein P53
25%
Infarction
25%
Neoplasm
22%
Small Interfering RNA
16%
Scar Formation
10%
Collagen Type 7
10%
Heart Muscle Ischemia
8%
Heart Ventricle Remodeling
8%
Congestive Heart Failure
8%
Rat Model
8%
Biological Marker
8%
Antiapoptotic
8%
Enzyme-Linked Immunosorbent Assay
8%
Carcinogenesis
7%
Inflammation
7%
Epidermolysis bullosa
7%
Melanoma
7%
Malignant Neoplasm
7%
Anticarcinogen
7%
Pharmacotherapy
7%
Medicine and Dentistry
Squamous Cell Carcinoma
83%
Drug Repositioning
50%
Transcriptome
50%
Proteoglycan
50%
Proteochondroitin Sulfate
50%
Epidermolysis Bullosa Dystrophica
33%
Neoplasm
33%
Skin Carcinoma
16%
Organ Transplantation
16%
Selumetinib
16%
Transplantation
16%
Specific Tumor
16%
Immunosuppressive Treatment
16%
Neck
16%
In Silico
16%
Cancer
14%
Diagnostic Marker
14%
Melanoma
7%
Gene Expression
7%
Clinician
7%
Anticarcinogen
7%
Angiogenesis
7%
Cell Surface
7%
Delayed Diagnosis
7%
Drug Therapy
7%
Cell Invasion
7%
Tumor Cell
7%
Carcinogenesis
7%
Malignant Neoplasm
7%
Extracellular Matrix
7%
Epidermolysis bullosa
7%
Biochemistry, Genetics and Molecular Biology
Chondroitin Sulfate Proteoglycan
50%
Proteoglycan
50%
Keratin 14
37%
Yeast Two-Hybrid Screening
12%
Protein Modeling
12%
Intermediate Filament
12%
Keratin
12%
Cell Invasion
7%
Anticancer
7%
Carcinogenesis
7%
Gene Expression
7%
Epidermolysis bullosa
7%
Angiogenesis
7%